Siolta Therapeutics
PrivateLast Round
Series C
Feb 23, 2024
Total Funding Raised
$44.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Siolta Therapeutics is a biotechnology company that develops microbiome-based live biotherapeutic products to prevent and treat inflammatory and atopic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Siolta Therapeutics Comparables
Compare Siolta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MatriSys Bioscience | 83% | |
| Vedanta Biosciences | 81% | |
| Microbiotica | 79% |
Siolta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 23, 2024 | ||||
| Grant | Feb 9, 2022 | ||||
| Series B | Sep 22, 2020 |
Siolta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Series B, Series C |
| National Institute of Allergy and Infectious Diseases | Grant |
| TIME Ventures | Series C |
| TIME Ventures | Series C |
| Khosla Ventures | Series B, Series A, Series C |
| Seventure Partners | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 84% MoM, from 1.1K to 2K.
- Feb 23, 2024
$12M round led by Khosla Ventures and SymBiosis Capital Management.
Siolta Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Siolta Therapeutics's valuation, stock price, and market status.
Is Siolta Therapeutics a public or private company?
Siolta Therapeutics is a private company.
What is the current stock price of Siolta Therapeutics?
Siolta Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Siolta Therapeutics worth (valuation)?
Valuation information for Siolta Therapeutics is not publicly available.
Can I buy Siolta Therapeutics stock?
Siolta Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Siolta Therapeutics's last funding round?
Siolta Therapeutics's most recent funding round was Series C on March 12, 2024.
Who are the main investors in Siolta Therapeutics?
Key investors in Siolta Therapeutics include Khosla Ventures.
Will Siolta Therapeutics IPO soon?
No public IPO plans have been announced for Siolta Therapeutics.
How can I track Siolta Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Siolta Therapeutics's secondary market activity and sign up for updates.